Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug;103(8):e380-e381.
doi: 10.3324/haematol.2018.198523.

Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma

Hugo J A Adams  1 , Thomas C Kwee  2
Affiliations
Comment

Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma

Hugo J A Adams et al. Haematologica. 2018 Aug.
No abstract available

Keywords: bone marrow microenvironment; hematopoiesis; hematopoietic stem cell; stem cell transplantation.

PubMed Disclaimer

Comment in

Comment on

References

    1. Melani C, Advani R, Roschewski M, et al. End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making. Haematologica. 2018. May 10 [Epub ahead of print] - PMC - PubMed
    1. Giulino-Roth L, O’Donohue T, Chen Z, et al. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol. 2017;179(5):739–747. - PMC - PubMed
    1. Goldschmidt N, Kleinstern G, Orevi M, et al. Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy. Cancer Chemother Pharmacol. 2016;77(5):1053–1060. - PubMed
    1. Vassilakopoulos TP, Pangalis GA, Chatziioannou S, et al. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia. 2016;30(1):238–242. - PubMed
    1. Adams HJ, Nievelstein RA, Kwee TC. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol. 2015;170(2):185–191. - PubMed

Substances

LinkOut - more resources